[{"NetIncomeLoss_1_Q1_USD":-21284000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"DepreciationAndAmortization_1_Q1_USD":255000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":5953000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":33532405.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":-3000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":1252000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-16000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":73749000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":5000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":29000.0,"AssetsCurrent_0_Q1_USD":456851000.0,"StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_1_Q1_USD":613000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":5463113.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":2657000.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q1_USD":139000.0,"IncomeTaxesPaidNet_1_Q1_USD":10000.0,"CommonStockSharesIssued_0_Q1_shares":36131275.0,"Assets_0_Q1_USD":459566000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":7200000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":5000.0,"Liabilities_0_Q1_USD":90674000.0,"OtherAssetsNoncurrent_0_Q1_USD":47000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":18613000.0,"EarningsPerShareBasic_1_Q1_USD":-0.63,"AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_0_Q1_USD":7199000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-3147000.0,"LettersOfCreditOutstandingAmount_0_Q1_USD":275000.0,"ProceedsFromStockPlans_1_Q1_USD":613000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":17000.0,"AccountsReceivableNetCurrent_0_Q1_USD":2759000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":395985000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":4000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":240579000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q1_USD":4442000.0,"CostsAndExpenses_1_Q1_USD":24566000.0,"RestrictedCash_0_Q1_USD":275000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":86000000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-21279000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-1566000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":-1942000.0,"ShareBasedCompensation_1_Q1_USD":4442000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"AccruedRentNoncurrent_0_Q1_USD":30000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":3265000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-163796000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":293938000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-4555000.0,"CommonStockSharesOutstanding_0_Q1_shares":36131275.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":12200000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-21284000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-20390000.0,"AccruedRentCurrent_0_Q1_USD":175000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":33532405.0,"AccountsPayableCurrent_0_Q1_USD":2274000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":396260000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":5768000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":2518000.0,"AdditionalPaidInCapital_0_Q1_USD":532700000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":5000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2393000.0,"LiabilitiesCurrent_0_Q1_USD":34070000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-84000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":51000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":56574000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":7231000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1_Q1_USD":5000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1772000.0,"CommonStockSharesAuthorized_0_Q1_shares":400000000.0,"OperatingIncomeLoss_1_Q1_USD":-21301000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":52339000.0,"OtherNonoperatingExpense_1_Q1_USD":12000.0,"ProceedsFromIssuanceInitialPublicOffering_1_Q1_USD":230217000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":24422000.0,"PreferredStockValue_0_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":459566000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2186000.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":4442000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":50800000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.63,"ProfitLoss_1_Q1_USD":-21284000.0,"StockholdersEquity_0_Q1_USD":368892000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":-19000.0,"ConversionOfStockAmountConverted1_1_Q1_USD":186000.0,"Ticker":"MORF","CIK":"1679363","name":"MORPHIC HOLDING, INC.","OfficialName":"Morphic Holding Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1330068663.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210429"}]